Related Experiment Video
Updated: May 24, 2026

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Eugenol-based meroterpenoids with neural differentiation activity from Eugenia caryophyllata
Cong Yan1, Sheng-Rui Yan1, Yutong Zhu1
1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Jinan University, Guangzhou, 510632, People's Republic of China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM & New Drugs Research, Guangdong-Hong Kong-Macau Joint Laboratory for Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University, Guangzhou, 510632, People's Republic of China; Center for Bioactive Natural Molecules and Innovative Drugs Research, College of Pharmacy, Jinan University, Guangzhou, 510632, People's Republic of China.
Abstract:
Phytochemical investigation of Eugenia caryophyllata buds led to the discovery of nine previously undescribed eugenol-based meroterpenoids, named eugenianols A-I (1-9). Among them, compound 1 is the first reported meroterpenoid featuring a eugenol moiety fused with a sesquiterpenoid unit via two C-C bonds, forming an unprecedented tricyclo[9.4.0.04,7]pentadecane core skeleton. Compounds 2-5 represent a class of meroterpenoids with unprecedented architectures characterized by distinct C-C bond linkage patterns between the eugenol and sesquiterpenoid moieties. Notably, the unusual linkage of 4 resulted in a rare configurationally stable Csp2-Csp3 chiral axis combining both axial and point chirality. Compounds 6-9 constitute a class of undescribed ether bridged eugenol-based meroterpenoids. Their structures were elucidated through comprehensive spectroscopic techniques, single-crystal X-ray diffraction, and quantum-chemical calculations. A plausible biosynthetic pathway for these eugenol-based meroterpenoids was proposed. Furthermore, biological evaluations revealed that compound 7 significantly promoted neural differentiation-promoting activity, indicating potential neuroprotective properties.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
08:03Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays
Published on: March 7, 2025
Related Concept Videos
Neurochemical Transmission: Sites of Drug Action
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drugs Affecting Neurotransmitter Release or Uptake
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS Stimulants: Psychedelic Agents
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...